Your session is about to expire
← Back to Search
Testosterone Therapy for Prostate Cancer
Study Summary
This trial is testing a possible new treatment for prostate cancer that could be more effective and have fewer side effects than current options.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My cancer has grown or spread according to recent scans.I have stomach or intestine problems that could affect medicine absorption.I have not had a heart attack in the last 6 months.I have had a seizure before or lost consciousness/had a mini-stroke in the last year.I haven't had cancer, except for certain skin or superficial bladder cancers, in the last 5 years.I have brain metastasis or active leptomeningeal disease.My prostate cancer was confirmed by a lab test.I have been on hormone therapy for prostate cancer for at least 6 months.I need a catheter to urinate because of prostate issues.I have not had radiation therapy in the last 2 weeks.I haven't had cancer treatment with drugs or biological therapy in the last 2 weeks.I am a man and will use two forms of birth control, including condoms, with my partner during and 3 months after the study.I do not have a pacemaker and have severe heart rhythm issues or very high blood pressure.I have been treated with drugs like enzalutamide or apalutamide before.I have not had unstable chest pain in the last 3 months.I have stopped taking first-generation anti-androgen drugs for at least 6 weeks and my PSA levels are still rising.I am a man and will use two forms of birth control, including condoms, with my partner during and for 3 months after the study.I have received multiple treatments for my castration-resistant condition.I do not have serious heart disease.I am a man and at least 18 years old.I have received multiple treatments for my castration-resistant condition.If you have sex with a pregnant woman, you must use a condom.My worst pain in the last day was less than 4 out of 10, and I don't take daily painkillers for cancer pain.My worst pain in the last day was less than 4 out of 10, and I don't take daily painkillers for cancer pain.My cancer has spread, shown by scans or previous tests.My cancer is in a place where treatment could make it worse.I am a man and at least 18 years old.My scans show my cancer has grown or spread.I stopped taking first-generation anti-androgen drugs 6 weeks ago and my PSA levels are still rising.I have a serious heart rhythm problem.I have been on hormone therapy for prostate cancer for at least 6 months.I have severe heart failure.My prostate cancer was confirmed by a lab test.My cancer has spread, shown by scans or previous tests.
- Group 1: Square Wave Testosterone Therapy + SOC
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I qualified to participate in this experiment?
"This clinical trial is recruiting participants with prostate cancer, aged 18 and over. The requisite criteria that must be met include: willingness to commit to the study's duration; a 6-week gap between stopping first-generation anti-androgens and randomization; worst pain in last 24 hours rated at 4 or below on a 0 to 10 scale; no daily use of narcotics for treating cancer-related pain (assessment during screening window to be documented); male gender; age 18 years old or older."
How many participants are conducting this research study?
"This clinical trial has halted participant recruitment for the time being. Initially published on January 18th 2019, this study was last amended on May 12th 2022. As an alternative, there are a total of 1324 trials recruiting prostate cancer patients and 126 studies in need of volunteers to test Transdermal Testosterone."
Could you elucidate other research endeavors that have explored Transdermal Testosterone?
"Currently, 126 clinical trials for transdermal testosterone are ongoing and 35 of these studies have reached their third phase. The majority of the investigations are located in Germantown, Tennessee yet a total of 5863 sites nationwide feature this medication trial."
Does this research endeavor currently require any new participants?
"Unfortunately, this medical trial is not currently open to recruitment. It was first advertised on January 18th 2019 and the latest update occurred on May 12th 2022. However, there are 1,324 trials recruiting for prostate cancer treatment and 126 studies searching for participants with Transdermal Testosterone issues."
Does this research involve minors under the age of 20?
"This study is currently seeking patients that are of legal age (18+) and under the century mark."
In what cases is Transdermal Testosterone typically administered?
"Sufferers of hypogonadotropic hypogonadism, post-menopausal women with 1 to 5 years since last period and orchidectomy can all benefit from the use of Transdermal Testosterone."
Share this study with friends
Copy Link
Messenger